Comparison of HTK-Custodiol and St-Thomas solution as cardiac preservation solutions on early and midterm outcomes following heart transplantation. [PDF]
Interdiscip Cardiovasc Thorac Surgpeer reviewed[en] OBJECTIVES: The choice of the cardiac preservation solution for myocardial protection at time of heart procurement remains controversial and uncertainties persist regarding its effect on the early and midterm heart transplantation (HTx)
Dulguerov F +15 more
europepmc +3 more sources
Source, triggers and clinical implications of hyperlactemia in patients undergoing mitral valve surgery using Custodiol cardioplegia [PDF]
, 2013 Postoperative blood hyperlactaemia is an indicator of organ anaerobic metabolism and is associated with morbidity after cardiac surgery. This prospective study aims to explore the source, triggers and clinical implications for hyperlactaemia in patients ...
Zanchettin, Chiara +7 more
core +1 more source
, 2020 Background: Cardioplegic solutions are widely used for myocardium protection during cardiac surgery. Custodiol cardioplegia has begun to gain popularity in recent years in cardiac surgery because of its administration, in a single dose, providing protection for 1.5 - 2 hours.
Bouzoukis, Dionusios, Grammenou, Georgia
openaire +2 more sources
Correction: Blood cardioplegia or custodiol for myocardial protection during valvular or aortic surgery: a propensity score adjusted comparison [PDF]
Journal of Cardiothoracic SurgeryManuel Carnero-Alcazar +9 more
doaj +2 more sources
Custodiol versus Plegisol: A phase 3 multicentre myocardial protection study [PDF]
International Journal of Angiology, 2008 While considered simple and effective, crystalloid antegrade cardioplegia solutions have had few prospective multicentre comparison trials.A commercial intracellular-type histidine-tryptophan-ketoglutarate (HTK) cardioplegia solution (Custodiol HTK; Köhler Chemie GmbH, Germany) designed for 4 h of protection after a single administration was compared ...
Todd L, Demmy +6 more
openaire +2 more sources
Custodiol Normacor I-V data and patients' data
, 2023 I-V data (INa, ICa,L and IKs) of cardiomyocytes and patients' data after operations using cardioplegic solutions Custodiol and ...
Sheida Frolova, Kovalenko Sandaara
core +1 more source
Theoretical and Practical Aspects in the Use of Bretschneider Cardioplegia
Journal of Cardiovascular Development and Disease, 2022 The race for an ideal cardioplegic solution has remained enthusiastic since the beginning of the modern cardiac surgery era. The Bretschneider solution, belonging to the “intracellular cardioplegic” group, is safe and practical in myocardial protection ...
Claudiu Ghiragosian +8 more
doaj +1 more source
Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience [PDF]
European Journal of Cardio-Thoracic Surgery, 2012 A single or dual-dose strategy for myocardial protection is attractive in long operations, in avoiding the need to interrupt the procedure to re-administer cardioplegia. We hypothesized that a single administration of Bretschneider histidine-tryptophan-ketoglutarate (HTK) crystalloid solution (Custodiol) offers myocardial protection comparable with ...
Fabiano F, Viana +5 more
openaire +2 more sources
Journal of Medicine in Scientific Research, 2019 Background Cardioplegia is responsible for myocardial protection during open heart surgery. Cardioplegia was first presented as an agent for hypothermic hyperkalemic arrest.
Ahmed S Ali +4 more
doaj +1 more source
In situ reconstruction of distal renal artery aneurysm with renal perfusion: A case series
Annals of Vascular Surgery - Brief Reports and Innovations, 2023 The treatment of renal artery aneurysms located from the mid to distal portion of the vessel is challenging. The complexity is related to the frequent involvement of side branches and to the risk of postoperative renal impairment. We report five cases of
Francesca Montanari +6 more
doaj +1 more source